Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 104 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| KLHL6 | ENSG00000172578 | 0.00 | 0.00 | 0 | 0 |
| SMPDL3A | ENSG00000172594 | 0.00 | 0.12 | 0 | 1 |
| OR10AD1 | ENSG00000172640 | 0.00 | 0.00 | 0 | 0 |
| MOS | ENSG00000172680 | 0.00 | 0.00 | 0 | 0 |
| CCL19 | ENSG00000172724 | 0.00 | 0.00 | 0 | 0 |
| OR4D9 | ENSG00000172742 | 0.00 | 0.00 | 0 | 0 |
| COL6A5 | ENSG00000172752 | 0.00 | 0.00 | 0 | 0 |
| OR5B3 | ENSG00000172769 | 0.00 | 0.00 | 0 | 0 |
| OR10W1 | ENSG00000172772 | 0.00 | 0.00 | 0 | 0 |
| CYP7B1 | ENSG00000172817 | 0.00 | 0.00 | 0 | 0 |
| RARG | ENSG00000172819 | 0.00 | 0.00 | 0 | 0 |
| CES3 | ENSG00000172828 | 0.15 | 0.00 | 1 | 0 |
| EGFL7 | ENSG00000172889 | 0.00 | 0.22 | 0 | 1 |
| LVRN | ENSG00000172901 | 0.00 | 0.00 | 0 | 0 |
| MRGPRD | ENSG00000172938 | 0.00 | 0.00 | 0 | 0 |
| SLC22A13 | ENSG00000172940 | 0.00 | 0.00 | 0 | 0 |
| KAT5 | ENSG00000172977 | 0.18 | 0.00 | 1 | 0 |
| RELA | ENSG00000173039 | 0.18 | 0.00 | 1 | 0 |
| RXFP4 | ENSG00000173080 | 0.00 | 0.00 | 0 | 0 |
| HPSE | ENSG00000173083 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 104 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.